Evidence map›Paper›PMID 32797733›Full record

ArticleJournal of neurochemistry2021

Glycogen synthase kinase-3ß supports serotonin transporter function and trafficking in a phosphorylation-dependent manner.

Durairaj Ragu Varman, Lankupalle D Jayanthi, Sammanda Ramamoorthy

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Durairaj Ragu VarmanDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Lankupalle D JayanthiDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
Sammanda RamamoorthyDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.ORCID 0000-0003-1093-7887
Virginia Commonwealth University · US

Funding

In Vivo Serotonin Transporter Dysregulation in Psychiatric DisordersR01MH112731 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI RAMAMOORTHY, SAMMANDA · 2018 to 2020
$1.2M
NIMH NIH HHS R01 MH112731
6 · The paper itself

Abstract

Serotonin (5-HT) transporter (SERT) plays a crucial role in serotonergic transmission in the central nervous system, and any aberration causes serious mental illnesses. Nevertheless, the cellular mechanisms that regulate SERT function and trafficking are not entirely understood. Growing evidence suggests that several protein kinases act as modulators. Here, we delineate the molecular mechanisms by which glycogen synthase kinase-3ß (GSK3ß) regulates SERT. When mouse striatal synaptosomes were treated with the GSK3α/ß inhibitor CHIR99021, we observed a significant increase in SERT function, V

Indexed as

AnimalsDose-Response Relationship, DrugGlycogen Synthase Kinase 3 betaHEK293 CellsHumansMaleMiceMice, Inbred C57BLPhosphorylationProtein TransportPyridinesPyrimidinesSerotoninSerotonin Plasma Membrane Transport ProteinsChir 99021Glycogen Synthase Kinase 3 betaPyridinesPyrimidinesSerotoninSerotonin Plasma Membrane Transport Proteinsglycogen synthase kinase-3phosphorylationserotonergic transmissionserotonin transportertraffickinguptake

Identifiers

PMID32797733
PMCPMC7882002
OpenAlexW3049329274

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.